Regulation of human MAPT gene expression - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Molecular Neurodegeneration Année : 2015

Regulation of human MAPT gene expression

Résumé

The number of known pathologies involving deregulated Tau expression/metabolism is increasing. Indeed, in addition to tauopathies, which comprise approximately 30 diseases characterized by neuronal aggregation of hyperphosphorylated Tau in brain neurons, this protein has also been associated with various other pathologies such as cancer, inclusion body myositis, and microdeletion/microduplication syndromes, suggesting its possible function in peripheral tissues. In addition to Tau aggregation, Tau deregulation can occur at the expression and/or splicing levels, as has been clearly demonstrated in some of these pathologies. Here, we aim to review current knowledge regarding the regulation of human MAPT gene expression at the DNA and RNA levels to provide a better understanding of its possible deregulation. Several aspects, including repeated motifs, CpG island/methylation, and haplotypes at the DNA level, as well as the key regions involved in mRNA expression and stability and the splicing patterns of different mRNA isoforms at the RNA level, will be discussed.

Dates et versions

inserm-04532389 , version 1 (04-04-2024)

Identifiants

Citer

Marie-Laure Caillet-Boudin, Luc Buée, Nicolas Sergeant, Bruno Lefebvre. Regulation of human MAPT gene expression. Molecular Neurodegeneration, 2015, 10 (1), pp.28. ⟨10.1186/s13024-015-0025-8⟩. ⟨inserm-04532389⟩

Collections

INSERM UNIV-LILLE
2 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More